29th October 2024, Tuesday

TechPharus

Latest Posts

HealthTech News

  • New research finds that subtle eye movements optimize vision
    on October 29, 2024 at 8:00 am

    Our ability to see starts with the light-sensitive photoreceptor cells in our eyes. A specific region of the retina, termed fovea, is responsible for sharp vision. Here, the color-sensitive cone photoreceptors allow us to detect even the smallest details. The density of these cells varies from person to person. Additionally, when we fixate on an object, our eyes make subtle, continuous movements, which also differ between individuals.

  • Covid-19 vaccine delays cost Australia $20 billion
    on October 29, 2024 at 7:45 am

    Australia’s sluggish COVID-19 vaccine rollout cost the nation at least $20 billion as strict lockdowns and other restrictions were unnecessarily prolonged, a government-backed inquiry concluded on Tuesday.

  • From concert piano to fear memory research, researcher bridges mouse-human studies
    on October 29, 2024 at 5:00 am

    In a new interview published in Brain Medicine, Dr. Raül Andero Galí reveals how his early passion for classical piano shaped his unique approach to neuroscience research. As an ICREA Research Professor at the Autonomous University of Barcelona, Dr. Andero Galí leads groundbreaking studies that connect mouse and human fear responses, potentially revolutionizing treatments for PTSD and anxiety disorders.

  • Scientists develop tool to predict sepsis in apparently healthy newborns
    on October 28, 2024 at 11:30 pm

    A genetic signature in newborns can predict neonatal sepsis before symptoms even start to show, according to a new study.

  • Synthetic vitamin K precursor found to slow progression of prostate cancer in lab mice
    on October 28, 2024 at 10:50 pm

    A team of molecular biologists and other medical specialists at Cold Spring Harbor Laboratory in New York, working with a large number of international partners, reports evidence that a synthetic vitamin K precursor can be used to slow the progression of prostate cancer in lab mice.